← Open Payments lookup

KATHARINE MCLEESE: Open Payments

NPI 1821107947 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$699 in 46 payments from 17 companies in 2025. Trend: 2023 $694 · 2024 $723 · 2025 $699

Food & beverage: $699
CompanyPaymentsAmount
Lilly USA, LLC13$150
Sumitomo Pharma America, Inc.3$64
Astellas Pharma US Inc3$59
ABBVIE INC.3$54
Novo Nordisk Inc3$52
AstraZeneca Pharmaceuticals LP3$52
PFIZER INC.3$47
Merck Sharp & Dohme LLC3$46
Boehringer Ingelheim Pharmaceuticals, Inc.2$37
Amgen Inc.2$27

Products named: MOUNJARO, GEMTESA, Veozah, GARDASIL 9, EVENITY, JARDIANCE, LINZESS, Rybelsus.

Industry payments across NE — which companies pay providers there.